Castilia Life Sciences LLP has formalized the vesting of shares in Hikal Limited, previously held by Castilia Life Sciences Private Limited. This transfer follows the statutory conversion of the Private Limited entity into the current Limited Liability Partnership (LLP), effective February 17, 2026. The total resulting shareholding of the acquirer and its Persons Acting in Concert (PACs) now stands at 34.83% of the total voting capital.
Corporate Conversion Triggers Share Vesting
Castilia Life Sciences LLP has formally disclosed a change in shareholding concerning Hikal Limited (BSE: 524735, NSE: HIKAL). The acquisition event documented is not a traditional purchase but a mandatory vesting pursuant to the conversion of the former promoter entity, Castilia Life Sciences Private Limited (“Castilia Co”), into the current Limited Liability Partnership (“Castilia LLP”). This corporate restructuring received approval, with the Certificate of Registration issued on February 17, 2026.
Consequently, all assets, rights, liabilities, and interests, including the shareholding in Hikal Limited, have vested automatically in Castilia LLP.
Pre-Acquisition Shareholding Analysis (PACs Only)
Before the vesting event, the acquirer (Castilia LLP) held no shares, as it was not in existence. However, the combined holding of the Persons Acting in Concert (PACs) was substantial:
- Total pre-vesting voting rights held by PACs: 1,27,20,100 shares.
- This represented 10.31% of the total share capital.
Key individual holdings within the PAC group included Sugandha Hiremath (7.84%) and Jai Hiremath (1.09%).
Post-Vesting Shareholding Position
Following the conversion and vesting on February 17, 2026, the total holding attributed to the Acquirer and PACs has significantly increased:
- Shares acquired/vested: 3,02,31,914 equity shares, representing 24.52% of the capital.
- The combined total shares carrying voting rights now stand at 4,29,52,014.
- This aggregate holding constitutes 34.83% of the total voting capital of Hikal Limited.
Capital Structure Details
The transaction involved no open market purchase, rights issue, or preferential allotment; it was purely an inter-se transfer/vesting resulting from the conversion process.
The equity share capital/total voting capital of Hikal Limited remained constant:
- Before the said acquisition: 12,33,00,750.
- After the said acquisition: 12,33,00,750.
The filing confirms that the entire existing shareholding of the previous entity has successfully vested with the new LLP structure.
Source: BSE
